CATO SMS Revenue and Competitors

Location

N/A

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • CATO SMS's estimated annual revenue is currently $113.4M per year.(i)
  • CATO SMS's estimated revenue per employee is $201,000

Employee Data

  • CATO SMS has 564 Employees.(i)
  • CATO SMS grew their employee count by 62% last year.

CATO SMS's People

NameTitleEmail/Phone
1
VP, Regulatory Strategy, Head, Cell & Gene TherapyReveal Email/Phone
2
VP Regulatory Affairs and Principal ScientistReveal Email/Phone
3
Head Integration Management OfficeReveal Email/Phone
4
VP, QualityReveal Email/Phone
5
Human Resources DirectorReveal Email/Phone
6
Sr. Director, Global Project ManagementReveal Email/Phone
7
Associate Director FinanceReveal Email/Phone
8
Chief Administrative Officer & General CounselReveal Email/Phone
9
Chief Revenue OfficerReveal Email/Phone
10
Chief Medical OfficerReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$5.8M294%N/AN/A
#2
$3.2M160%N/AN/A
#3
$83.2M4147%N/AN/A
#4
$31M15456%N/AN/A
#5
$66.6M2650%$35MN/A
#6
$10.9M546%N/AN/A
#7
$6.8M34-6%N/AN/A
#8
$165.7M21614%$250.7MN/A
#9
$26.5M132-11%$637.8KN/A
#10
$49.4M2466%N/AN/A
Add Company

What Is CATO SMS?

CATO SMS experts deliver specialized drug development services and solutions, designing and executing studies in complex indications and modalities. We have the experts to tackle your toughest challenges with confidence and precision. With over 30 years of experience focusing on the needs of small and emerging companies, our team is optimized to deliver for sponsors like you. Our expert teams effectively design and execute studies — from strategy to approval — in complex indications and modalities across a variety of therapeutic areas, with a proven center of excellence in oncology. We deliver effective strategies and innovative solutions to guide you through the most complex regulatory challenges. Our combination of regulatory, therapeutic, and operational expertise enables us to meet your goals and exceed expectations. We provide valuable insight, high-quality deliverables, and unmatched client service, giving you expert guidance to identify the specialized solutions you need, every step of the way. We know how important your product is to you and the patients who are waiting. You’re in this industry because you want to make a difference in the health and lives of patients. You put everything you have into your product, so you’ll accept nothing but the best from the teams you choose. When the stakes are this high, you need a high-performance partner. You need CATO SMS.

keywords:N/A

N/A

Total Funding

564

Number of Employees

$113.4M

Revenue (est)

62%

Employee Growth %

N/A

Valuation

N/A

Accelerator

CATO SMS News

2022-03-22 - CATO SMS to serve as CRO partner for GeoVax's Covid-19 ...

GeoVax Labs has engaged CATO SMS as the company's clinical research organisation (CRO) partner to manage two Phase II clinical trials of its...

2020-09-15 - CATO SMS Acquires Array Biostatistics

CARY, N.C., Sept. 15, 2020 /PRNewswire/ -- CATO SMS announced today that it has acquired Wilmington, NC-based Array Biostatistics (Array) to expand its offering of specialized clinical research solutions. The company plans to invest in growing Array and its highly regarded biostatistical capab ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$85.2M568-1%N/A
#2
$208.4M57563%N/A
#3
$233.5M5824%N/A
#4
$118.9M65662%N/A
#5
$232.2M688-1%N/A